A prospective randomized comparison of two distinct allogenic tissue constructs for anterior cruciate ligament reconstruction

Our data indicate no difference in graft failure rate and similar improvement from baseline in most PRO scores between treatment groups after two years. Based on these findings, TA allograft appears to provide a reliable and satisfactory option for patients who elect to undergo allograft ACL reconstruction.